Johnson & Johnson and Legend Biotech’s Carvykti shows improved survival in treatment-experienced multiple myeloma patients
As a 2nd line therapy for multiple myeloma, Carvykti can lower the risk of disease progression or death by 59% ...
Tag: Johnson & Johnson
Single-dose Ad26.COV2.S reduces risk of COVID-related hospitalization and death in South African healthcare workers
1. Single-dose of Ad26.COV2.S reduces risk of COVID-related hospitalization by 67% compared to matched unvaccinated control group. 2. Breakthrough infections ...
#VisualAbstract: COVID-19 vaccines provided durable protection from COVID-19, but their effectiveness waned over time in North Carolina
1. Three Covid-19 vaccines from Pfizer, Moderna, and Johnson & Johnson provided durable protection against hospitalization and death. 2. However, ...